Tiotropium bromide is a new quaternary ammonium compound with anticholinergic properties specific for muscarinic receptors (M1, M2, and M3) in humans. [1] Because acetylcholine modulates bronchial ...
Details concerning the Tiotropium Bromide combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...
The drug aclidinium bromide (trade names Eklira®, Bretaris®) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The ...
Please provide your email address to receive an email when new articles are posted on . The use of tiotropium bromide may be beneficial in the treatment of patients with moderate to severe asthma, ...
A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported ...
SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
First head-to-head study comparing common treatments for patients with COPD shows quality of life and survival benefits for patients treated with Seretide The INSPIRE (Investigating New Standards for ...
Research and Markets (http://www.researchandmarkets.com/research/rvchgj/investigation) has announced the addition of the "Investigation Report on China Tiotropium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results